Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness ; day:10 ; month:6 ; year:2024 ; pages:1-11
The international journal of cardiovascular imaging ; (10.6.2024), 1-11
- Creator
-
Holcman, Katarzyna
Kostkiewicz, Magdalena
Szot, Wojciech
Ćmiel, Bogdan
Mróz, Krystian
Stępień, Agnieszka
Graczyk, Katarzyna
Dziewięcka, Ewa
Karabinowska-Małocha, Aleksandra
Sachajko, Zuzanna
Podolec, Piotr
Rubiś, Paweł
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10554-024-03158-z
- URN
-
urn:nbn:de:101:1-2408162130065.461995566959
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Holcman, Katarzyna
- Kostkiewicz, Magdalena
- Szot, Wojciech
- Ćmiel, Bogdan
- Mróz, Krystian
- Stępień, Agnieszka
- Graczyk, Katarzyna
- Dziewięcka, Ewa
- Karabinowska-Małocha, Aleksandra
- Sachajko, Zuzanna
- Podolec, Piotr
- Rubiś, Paweł
- SpringerLink (Online service)
Other Objects (12)
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Transthyretin Amyloid Cardiomyopathy in a Young Female
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
RV-PA uncoupling is associated with increased mortality in transthyretin amyloid cardiomyopathy treated with tafamidis
Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Transthyretin Amyloid Cardiomyopathy in a Young Female
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
RV-PA uncoupling is associated with increased mortality in transthyretin amyloid cardiomyopathy treated with tafamidis
Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Transthyretin Amyloid Cardiomyopathy in a Young Female
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
RV-PA uncoupling is associated with increased mortality in transthyretin amyloid cardiomyopathy treated with tafamidis